A Prospective, Open-label Trial of Two Abacavir/Lamivudine Based Regimen (ABC/3TC + Darunavir/Ritonavir or ABC/3TC + Raltegravir) in Late Presenter naïve Patients (With CD4 Count <200 Cells/µL - Advanced HIV Disease)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2013 by University of Modena and Reggio Emilia.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Cristina Mussini, University of Modena and Reggio Emilia
ClinicalTrials.gov Identifier:
NCT01900106
First received: July 5, 2013
Last updated: July 11, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)